[1]CurrentPatentAssignee:AMGENINC-WO2007/98169,2007,A1Locationinpatent:Page/Pagecolumn53-54
[2]CurrentPatentAssignee:AMGENINC;ROCHEHOLDINGAG-WO2007/100880,2007,A1Locationinpatent:Page/Pagecolumn72-73
[1]CurrentPatentAssignee:INSILICOMEDICINEIPLIMITED-WO2020/198583,2020,A1Locationinpatent:Paragraph000187
[2]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2018/5881,2018,A1Locationinpatent:Page/Pagecolumn130
[3]CurrentPatentAssignee:AMGENINC-WO2007/98169,2007,A1Locationinpatent:Page/Pagecolumn53
[4]CurrentPatentAssignee:AMGENINC;ROCHEHOLDINGAG-WO2007/100880,2007,A1Locationinpatent:Page/Pagecolumn72
[1]CurrentPatentAssignee:COLUMBIAUNIVERSITYINTHECITYOFNEWYORK-WO2014/151959,2014,A1Locationinpatent:Page/Pagecolumn82
[1]CurrentPatentAssignee:COLUMBIAUNIVERSITYINTHECITYOFNEWYORK-WO2014/152013,2014,A1Locationinpatent:Page/Pagecolumn132;133
[1]Patent:WO2014/152013,2014,A1.Locationinpatent:Page/Pagecolumn107
Title: New IDH1 mutant inhibitors for treatment of acute myeloid leukemia.
Journal: Nature chemical biology 20151101